Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headlines

Headline Title

Solid Tumors

Clinical Trials

Solid Tumors Protocol Information

All Clinical Trials Information

Protocol Number Title Study Status PI Website Section
Pilot
07C0206 A Pilot Study of Tumor Vaccination and RHIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors Currently Accruing Mackall, Crystal
Link Solid Tumors
11C0113 A Pilot Study of Genetically Engineered NY-ESO-1 Specific (c259) T cells in HLA-A2+ Patients with Synovial Sarcoma Currently Accruing Mackall, Crystal
Link Solid Tumors
Phase 1
08C0007 A Phase I Study of Ipilimumab (Anti-CTLA4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer Currently Accruing Melinda, Merchant
Link Solid Tumors
Pharmacology and Experimental Therapeutics
10C0220 Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo® (Vincristine Sulfate Liposomes Injection) in Children and Adolescents with Refractory Cancer Currently Accruing Shah, Nirali
Link Solid Tumors
Neuro-Oncology
Hematologic Diseases
11C0047 Phase I trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors Not Currently Accruing Widemann, Brigitte
Link Solid Tumors
Neuro-Oncology
Pharmacology and Experimental Therapeutics
11C0073 A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias Currently Accruing Shah, Nirali
Link Hematopoietic Stem Cell Transplantation
Solid Tumors
Hematologic Diseases
12C0208 Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients with Relapsed or Refractory Solid Tumors Currently Accruing Widemann, Brigitte
  Pharmacology and Experimental Therapeutics
Solid Tumors
13C0042 ADVL1211: A Phase I Study of XL184 (Cabozantinib, IND# 116059) in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors Currently Accruing Widemann, Brigitte
  Solid Tumors
Pharmacology and Experimental Therapeutics
Neuro-Oncology
13C0064 An Open-Label, Multicenter, Single-Arm, Phase I Dose-Escalation with Efficacy Tail Extension Study of RO5185426 in Pediatric Patients with Surgically Incurable and Unresectable Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations Currently Accruing Merchant, Melinda
  Solid Tumors
Phase 1 & 2
10C0178 A Phase 1/2 Study of PF-02341066, An Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma Currently Accruing Widemann, Brigitte
Link Solid Tumors
Hematologic Diseases
Pharmacology and Experimental Therapeutics
12C0135 Phase I/II Trial of Mithramycin in Children and Adults with Refractory Extracranial Solid Tumors (Phase I) or Ewing Sarcoma and EWS-FLI1 Fusion Transcript (Phase II) Currently Accruing Widemann, Brigitte
Link Solid Tumors
Pharmacology and Experimental Therapeutics
Phase 2
12C0098 A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults with Relapsed / Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma Currently Accruing Widemann, Brigitte
Link Pharmacology and Experimental Therapeutics
Solid Tumors
Other
10C0086 Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies Currently Accruing Javed, Khan
Link Solid Tumors
12C0160 Validation of the English Version of the Pain Interference Index and the Pain Rating Scale in Children, Adolescents, and Young Adults With Chronic Illness and Their Parents Currently Accruing Peron, Staci
Link Psychosocial
Neurofibromatosis
Solid Tumors
Hematologic Diseases
Dashed Line

return to the top

This Page Last Reviewed on April 28, 2011

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov